Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP003510priorityCriticalpatent/ECSP003510A/en
Publication of ECSP003510ApublicationCriticalpatent/ECSP003510A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Dos formas polimórficas cristalinas de citrato de (2-benzhidril-1-azo-biciclo(2.2.2)oct-3-il)-(5-isopropil-2-metoxibencil)amina monohidrato (los monohidratos) son la forma A y la forma B. La composición farmacéutica que contiene al menos uno de estos polimorfos tiene una estabilidad ventajosa para la formulación para el tratamiento de émesis aguda en pacientes que reciben quimioterapia. La administarción de esta composición farmacéutica es convencionalmente oral, mediante preferiblemente comprimidos o cápsulas e intravenosa. Se describe también un procedimiento de obtención de las formas A y B.Two crystalline polymorphic forms of (2-benzhidril-1-azo-bicyclo (2.2.2) oct-3-yl) - (5-isopropyl-2-methoxybenzyl) amine monohydrate (the monohydrates) are Form A and Form B. The pharmaceutical composition containing at least one of these polymorphs has an advantageous stability for the formulation for the treatment of acute emesis in patients receiving chemotherapy. Administration of this pharmaceutical composition is conventionally oral, preferably by tablet or capsule, and intravenous. A procedure for obtaining forms A and B is also described.
ECSP0035102000-06-012000-06-01
POLYMORPHOS OF A AZOBICICLO CITRATE (2,2,2) OCT - 3 - CRYSTALLINE ILAMINE AND ITS PHARMACEUTICAL COMPOSITIONS
ECSP003510A
(en)
ADAMANTAN DERIVATIVES, PROCEDURES FOR THE PREPARATION, PHARMACEUTICAL COMPOSITION, PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITION, AND THE USE OF SUCH DERIVATIVES FOR THE MANUFACTURE OF MEDICINES
DERIVATIVES OF NAFTIRIDINES, A PROCESS FOR THE PREPARATION, PHARMACEUTICAL COMPOSITION AND THE USE OF THEM FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF AN INFLAMMATORY DISEASE
ENANTIOSELECTIVE PROCESS FOR THE PREPARATION OF BOTH ENANTIOMERS OF 10,11-DIHIDRO-10-HIDROXI-5H-DIBENZ- [b, f] -AZEPIN-5-CARBOXAMIDE AND ITS NEW GLASS FORMS
HPPARDELTA ACTIVATING COMPOUNDS, PHARMACEUTICAL COMPOSITION, ITS USE IN THE PREPARATION OF MEDICINES, METHOD FOR THE TREATMENT OF DISEASES MEDIATED BY HPPARDELTA
DERIVATIVES OF QUINOLINA. PROCEDURE FOR THE PREPARATION, PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM, AND THE USE OF THEM FOR THE MANUFACTURE OF A MEDICINE
COMPOUNDS DERIVED FROM OCTAHIDRO-PIRROLO [1,2-A] -PYRAZINE 2,7-SUBSTITUTES, PHARMACEUTICAL COMPOSITIONS AND USE OF SUCH COMPOUNDS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT.
DICETOPIPERAZINE COMPOSITE, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, USE OF THE COMPOUND FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AND PROCEDURE FOR THE PREPARATION OF THE SAME
PHARMACEUTICAL COMPOSITION THAT INCLUDES A CARBOXIALQUILETER AND AN ANTIHIPERTENSIVE AGENT, FIRST COMPOSITION FOR USE WITH A SECOND COMPOSITION THAT UNDERSTAND AN ANTIHIPERTENSIVE AGENT AND A CARBOXIALQUILETER RESPECTIVELY, TEAM UNDERSTANDING AN CARBOXIALQUTIETT